
MorningRX: September 14, 2023
FDA sends warning letters to 8 companies over unapproved eye drops, healthcare visits delivered by nurse practitioners and physician assistants continue to increase, and WHO agrees on the first-ever patient safety rights charter.
FDA Sends Warning Letters Over Unapproved Eye Drops
The FDA issued warning letters to 8 companies for marketing potentially dangerous unapproved eye drop products, according
“The FDA is committed to ensuring the medicines Americans take are safe, effective and of high quality,” Jill Furman, director of the Office of Compliance for the FDA’s Center for Drug Evaluation and Research, said in a release. “When we identify illegally marketed, unapproved drugs and lapses in drug quality that pose potential risks, the FDA works to notify the companies involved of the violations.”
More Health Visits Continue to be Delivered by Non-Physicians
A quarter of all health care visits in the United States are being delivered by nurse practitioners and physicians assistants, according to research
“The increase in care delivery by nurse practitioners and physician assistants represents a massive change,” Ateev Mehrotra, an author on the study,
WHO, Stakeholders Agree on Patient Safety Rights Charter
During a conference held Tuesday and Wednesday in Geneva, the World Health Organization and several stakeholders agreed on the first-ever patient safety rights charter,
“Patient safety is a collective responsibility,” Tedros Adhanom Ghebreyesus, WHO Director-General, said in a release. “Health systems must work hand-in-hand with patients, families, and communities, so that patients can be informed advocates in their own care, and every person can receive the safe, dignified, and compassionate care they deserve.”
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































